Vnitr Lek 2021, 67(Suppl.C):9-15 | DOI: 10.36290/vnl.2021.101

Civilizační nemoci - daň za moderní způsob života

MUDr. Zuzana Zafarová

Depresivní poruchy, jejich vzájemný vztah s kardiovaskulárními (KV) chorobami a chronické žilní onemocnění (CVD) byly jako typické civilizační nemoci dnešní doby tématem jednoho ze sympozií společnosti Servier na Výročním sjezdu České kardiologické společnosti v květnu 2021.

Published: October 25, 2021  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Zafarová Z. Civilizační nemoci - daň za moderní způsob života. Vnitr Lek. 2021;67(Suppl. C - Novinky v k):9-15. doi: 10.36290/vnl.2021.101.
Download citation

References

  1. GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018; 392(10159): 1789-1858. Go to original source... Go to PubMed...
  2. Wittchen HU, Jacobi F, Rehm J, et al. The size and burden of mental disorders and other disorders of the brain in Europe 2010. Eur Neuropsychopharmacol. 2011; 21(9): 655-679. Go to original source... Go to PubMed...
  3. Laursen TM, Musliner KL, Benros ME, et al. Mortality and life expectancy in persons with severe unipolar depression. J Affect Disord. 2016; 193: 203-207. Go to original source... Go to PubMed...
  4. Markkula N, Härkänen T, Nieminen T, et al. Prognosis of depressive disorders in the general population- results from the longitudinal Finnish Health 2011 Study. J Affect Disord. 2016; 190: 687-696. Go to original source... Go to PubMed...
  5. Birrer RB, Vemuri SP. Depression in later life: a diagnostic and therapeutic challenge. Am Fam Physician. 2004; 69(10): 2375-2382. Go to PubMed...
  6. Larsen KK, Christensen B, Søndergaard J, Vestergaard M. Depressive symptoms and risk of new cardiovascular events or death in patients with myocardial infarction: a population-based longitudinal study examining health behaviors and health care interventions. PLoS One. 2013; 8(9): e74393. Go to original source... Go to PubMed...
  7. Daskalopoulou M, George J, Walters K, et al. Depression as a Risk Factor for the Initial Presentation of Twelve Cardiac, Cerebrovascular, and Peripheral Arterial Diseases: Data Linkage Study of 1.9 Million Women and Men. PLoS One. 2016; 11(4): e0153838. Go to original source... Go to PubMed...
  8. Frasure-Smith N, Lespérance F. Depression--a cardiac risk factor in search of a treatment. JAMA. 2003; 289(23): 3171-3173. Go to original source... Go to PubMed...
  9. Denollet J, Pedersen SS, Daemen J, et al. Reduced positive affect (anhedonia) predicts major clinical events following implantation of coronary-artery stents. J Intern Med. 2008; 263(2): 203-211. Go to original source... Go to PubMed...
  10. Noordam R, Aarts N, Leening MJ, et al. Use of antidepressants and the risk of myocardial infarction in middle-aged and older adults: a matched case-control study. Eur J Clin Pharmacol. 2016; 72(2): 211-218. Go to original source... Go to PubMed...
  11. Penninx BW. Depression and cardiovascular disease: Epidemiological evidence on their linking mechanisms. Neurosci Biobehav Rev. 2017; 74(Pt B): 277-286. Go to original source... Go to PubMed...
  12. Leonard B, Maes M. Mechanistic explanations how cell-mediated immune activation, inflammation and oxidative and nitrosative stress pathways and their sequels and concomitants play a role in the pathophysiology of unipolar depression. Neurosci Biobehav Rev. 2012; 36(2): 764-785. Go to original source... Go to PubMed...
  13. Harrison NA, Brydon L, Walker C, et al. Inflammation causes mood changes through alterations in subgenual cingulate activity and mesolimbic connectivity. Biol Psychiatry. 2009; 66(5): 407-414. Go to original source... Go to PubMed...
  14. Amidfar M, Woelfer M, Réus GZ, et al. The role of NMDA receptor in neurobiology and treatment of major depressive disorder: Evidence from translational research. Prog Neuropsychopharmacol Biol Psychiatry 2019; 94: 109668. Go to original source... Go to PubMed...
  15. Setiawan E, Attwells S, Wilson AA, et al. Association of translocator protein total distribution volume with duration of untreated major depressive disorder: a cross-sectional study. Lancet Psychiatry. 2018; 5(4): 339-347. Go to original source... Go to PubMed...
  16. Ramasubbu R, Taylor VH, Samaan Z, et al; Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force. The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and select comorbid medical conditions. Ann Clin Psychiatry 2012; 24(1): 91-109. Go to PubMed...
  17. Cohen HW, Gibson G, Alderman MH. Excess risk of myocardial infarction in patients treated with antidepressant medications: association with use of tricyclic agents. Am J Med. 2000; 108(1): 2-8. Go to original source... Go to PubMed...
  18. Laghrissi-Thode F, Wagner WR, Pollock BG, et al. Elevated platelet factor 4 and beta-thromboglobulin plasma levels in depressed patients with ischemic heart disease. Biol Psychiatry 1997; 42(4): 290-295. Go to original source... Go to PubMed...
  19. Markovitz PJ. Recent trends in the pharmacotherapy of personality disorders. J Pers Disord. 2004; 18(1): 90-101. Go to original source... Go to PubMed...
  20. Sauer WH, Berlin JA, Kimmel SE. Selective serotonin reuptake inhibitors and myocardial infarction. Circulation. 2001; 104(16): 1894-1898. Go to original source... Go to PubMed...
  21. Birrer RB, Vemuri SP. Depression in later life: a diagnostic and therapeutic challenge. Am Fam Physician. 2004; 69(10): 2375-2382. Go to PubMed...
  22. Medvedev VE. Agomelatine in the treatment of mild-to-moderate depression in patients with cardiovascular disease: results of the national multicenter observational study PULSE. Neuropsychiatr Dis Treat. 2017; 13: 1141-1151. Go to original source... Go to PubMed...




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.